Assembly Biosciences (ASMB) EBIAT: 2015-2025
Historic EBIAT for Assembly Biosciences (ASMB) over the last 9 years, with Sep 2025 value amounting to -$9.2 million.
- Assembly Biosciences' EBIAT rose 4.34% to -$9.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$38.5 million, marking a year-over-year increase of 5.53%. This contributed to the annual value of -$40.2 million for FY2024, which is 34.38% up from last year.
- As of Q3 2025, Assembly Biosciences' EBIAT stood at -$9.2 million, which was up 9.83% from -$10.2 million recorded in Q2 2025.
- Over the past 5 years, Assembly Biosciences' EBIAT peaked at -$8.8 million during Q1 2025, and registered a low of -$60.3 million during Q4 2021.
- Its 3-year average for EBIAT is -$11.8 million, with a median of -$10.3 million in 2024.
- Its EBIAT has fluctuated over the past 5 years, first crashed by 461.45% in 2021, then spiked by 52.10% in 2024.
- Over the past 4 years, Assembly Biosciences' EBIAT (Quarterly) stood at -$60.3 million in 2021, then reached -$11.0 million in 2023, then rose by 5.72% to -$10.3 million in 2024, then climbed by 4.34% to -$9.2 million in 2025.
- Its EBIAT stands at -$9.2 million for Q3 2025, versus -$10.2 million for Q2 2025 and -$8.8 million for Q1 2025.